chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Violent shaking and chills, 100.1 fever, muscle aches, headache, dry mouth, pain in arm, nausea but no vomiting
Patient was given a dose of the Moderna Covid vaccine serum morning after the day it was opened ( Vial opened on 6/14/2021, Vaccine given 6/15/2021 8:30am)
Mother reported on 7-10-11 client c/o itching with swelling & hives to underarms bilaterally, arms, legs & top of (L) foot. Reports HA, tired with no fever. Appointment with PCP 7-11-11. PCP advised was reaction to MCV & instructed to take BENADRYL by mouth & prescribed generic DIPROLENE for areas of hives & itching. Injection site red & swollen.
Less than 48 ours after getting the vaccine my arms and legs started to ache. Muscles hurt when touched - legs felt weak. Also had a headache. Symptoms lasted until the morning of 10-21-13.
Extremely Weak after the second dose; Extremely Sick after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Extremely Weak after the second dose) and ILLNESS (Extremely Sick after the second dose) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No specified medical history has been reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced ASTHENIA (Extremely Weak after the second dose) and ILLNESS (Extremely Sick after the second dose). In February 2021, ASTHENIA (Extremely Weak after the second dose) and ILLNESS (Extremely Sick after the second dose) outcome was unknown.            Concomitant medications were not provided. Treatment information was not provided. She was researching as to what to expect from a third dose of the vaccine. She was immune compromised and she would like to know what to expect prior to getting a third shot.    This case was linked to MOD-2021-005642 (Patient Link).
denied further AE; temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.    On 04-OCT-2021, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), lot # KP24R, expiration date 24-OCT-2021 for prophylaxis (dose #, anatomical location and route of administration were not reported).   The vaccine was stored at the temperature that was reported as 50.5 degrees of Fahrenheit for 0 hours and 30 minutes. There was no previous temperature excursion reported.  The reporter denied further adverse events.   This is one of several reports received from the same reporter.  Lot Number KP24R is not valid for Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and does not match any Company product; Sender's Comments:  US-009507513-2110USA007288: US-009507513-2110USA007310: US-009507513-2110USA007275: US-009507513-2110USA007316: US-009507513-2110USA006972: US-009507513-2110USA007269: US-009507513-2110USA007007:
Muscle pain and burning increased over 24hrs after anthrax vaccination. Pain began to migrate down right arm. Severe swelling in right arm (vaccine arm). Transported to ER and started recieving steroids in afternoon of 16th. Swelling and pain began to migrate into left arm/side/back on evening of 16th. Patient states it feels like fire ants and lava going through her veins.
Extreme insomnia; This is a spontaneous report from a contactable consumer, the patient. A 35-years-old non pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: En6202) via unspecified route of administration in the left arm on 24Feb2021 at 13:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included Crohns, Ehlers-Danlos syndromes (EDS), migraines/headaches, to in the left arm on 24Feb2021 at 13:30urette's disorder. The patient was allergic to iodine contrast (reported as IV contrast). Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included multiple medications (unspecified) for multiple chronic illnesses. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested positive for COVID-19. On 25Feb2021 at 22:00, the patient had extreme insomnia, after receiving the second dose of the vaccine. The patient was unable to sleep more than a couple broken hours per night without taking diphenhydramine; ibuprofen (ADVIL PM). The clinical outcome of the event insomnia was not resolved at the time of the report.   No follow-up attempts are needed. No further information is expected.
Severe chills, whole body shook constantly, fever, light headed, faint feeling, sore arm at injection site.
Flu like symptoms. Feels warm all over body. Frequent urination. Seen by doctor during employment physical on 12-28-2009.
I started getting body aches and a headache. By the next day, I developed severe, severe body aches, fever, shortness of breath, cough and fatigue. I am still dealing with shortness of breath and cough.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 46-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunization. The patient had no relevant medical history and no known allergies. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid. Clinical course was reported as, On 11May2022 the patient experienced weird taste and mild lightheaded. Therapeutic measures were not taken as result of weird taste and mild lightheaded. The patient was recovered from symptoms.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on reported information, causal association of event drug ineffective, covid-19 with BNT162b2 cannot be excluded. However, response to vaccine can vary in individuals.
The child received the second dose of Pfizer covid vaccine on 1/27/22 the first dose was given only one week prior o 1/20/22. Mother was notified of vaccine error today on 2/10/2022. She reported that the child did not have any side effects from the vaccine.
was very healthy 43 year old male in good shape prior to this event. Started having minor internal vibrations 1 month after booster. No visible tremors initially. Persisted for about 3 months. On May 7th - started having near constant internal vibrations and brain fog. A few weeks later started having electrical pains in my feet, difficulty walking and bending, tingling in hands. Vibrations almost always present but move around my body (1 limb or just chest etc). No known patters.  Have mostly regained walking ability (almost completely, still occasional nerve twinge in feet, but vibrations persist.
Narrative:  VS: 1st set @ 1333 - bp 152/77, HR 50, Sats 94% RA. 2nd Set of VS @ 1339: bp 143/80, HR 50, Sats 98% RA. 3rd set VS @ 13:48: bp 136/79, HR 51, Sats 98% RA. 4th set of VS @ 14:00: bp 125/70, HR 50, Sats 98 RA.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 11-NOV-2015 at time- 01:08, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 4.4 and 2.7 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
Very high blood pressure. Possible stroke. Twice in the hospital so far. Dizzy, tired, with headaches.
Severe rash, peeling skin, red bumps. Areas affected: feet, hands, face, ears, neck, upper chest, knees, elbows.
Information has been received from a nurse concerning a female who on an unspecified date was vaccinated with 0.65 ml dose of Zostavax. Subsequently the patient developed shingles on her face. Unspecified medical attention was sought. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Tachycardia-Mild, Additional Details: Had to use 1 epi pen in left upper thigh
12/12/13 patient appeared with swollen upper arm area, erythema. We followed up 12/15/13 pt said entire trunk region was covered in rash. Patient said will make physician appointment.
Hospitalized on Oct 3rd with symptoms of stroke.  Stroke confirmed by hospital staff on Oct 4th and neurologist on reading films.  Mild stroke.  No prior cardiac or brain issues.  Normal blood pressure.
This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported. On 04-DEC-2017, the patient was vaccinated with an improperly stored dose of PROQUAD lot # N016994, expiration date 29-NOV-2018, for prophylaxis (strength, dose, route and frequency were not reported). The PROQUAD was reconstituted with a properly stored sterile diluent (MERCK) lot # M034763, expiration date 22-APR-2019. The temperature excursion was of 6°F to 14°F, during 120 hours 30 minutes. However, a previous temperature excursion of 47°F to 50°F for 35 minutes was also reported. A digital data logger was involved. No adverse effects were reported. Additional information is not expected. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1712USA013991: US-009507513-1801USA003525: US-009507513-1801USA003526: US-009507513-1801USA003527: US-009507513-1801USA003520: US-009507513-1801USA003521: US-009507513-1801USA003522: US-009507513-1801USA003523: US-009507513-1801USA003612.
Within 5 minutes of vaccine, a flush of heat came over my face and body, my heart started to race, and ended up in the emergency room.
pt recv vax & devel cellulitis;pt required incision & drainage of the site;
was delirious; got  real real sick; felt like having the flu; fever; This spontaneous case was reported by a consumer and describes the occurrence of DELIRIUM (was delirious), ILLNESS (got  real real sick), INFLUENZA LIKE ILLNESS (felt like having the flu) and PYREXIA (fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037a21b) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced DELIRIUM (was delirious), ILLNESS (got  real real sick), INFLUENZA LIKE ILLNESS (felt like having the flu) and PYREXIA (fever). On 19-Apr-2021, DELIRIUM (was delirious), ILLNESS (got  real real sick), INFLUENZA LIKE ILLNESS (felt like having the flu) and PYREXIA (fever) had resolved.            No treatment information was provided.   This case was linked to MOD-2021-395960 (Patient Link).
flu; got covid twice!!!; Initial information received on 16-Dec-2022 regarding an unsolicited valid non-serious case received from a consumer via social media.   This case involves an adult patient of unknown gender who experienced flu and got covid twice after receiving influenza vaccine.  It is unknown if the patient had any medical history, concomitant disease or risk factor. The patient's past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included covid-19 vaccine for Covid-19.  On an unknown date, the patient had received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, route, formulation, batch number and expiry date: unknown) in unknown administration site for flu (influenza).  On an unknown date, the patient developed events flu (influenza) and got covid twice (covid-19) (latency: unknown for both) following the administration of influenza vaccine.  It is unknown if the patient experienced any additional symptoms/events.   It is unknown if there were lab data/results available  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the events.   At time of reporting, the outcome was Unknown for the events.
Swelling to arm from shoulder to wrist.  No warmth. Redness to Left Deltoid. Benadryl and cool packs prescribed.
Dosing Interval incorrect: First Dose: 7-1-21; Second Dose: 7-29-21; Booster Dose: 11-10-21
Fever, chills, nausea, aches and pain throughout body and joints.  Chest pain which has continued with face numbness and tingling
Prolonged Menstrual Period LMP 23 Nov-Dec 2. Red Patchy Rash Dec 8 to present  (started on torso, then spread to back and down legs.)
Measles; gastroenteritis - Information has been received from a health professional concerning a 15 month old male who on 30 Nov 2000 was vaccinated with the first dose  of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live sencond generation lot # 635455/0782k.  concurrent therapy included the first dose of baricella virus vaccine live site unknown (MSD) 635606/1152K and he first dose of hepatitis b vaccine recombinant yeast (msd) 636070/0494k.  Other concomitant therapy included acetaminophen, ibuprofen motrin and amoxicillin.  It was noted that 2 -3 days after the vaccination the patient developed viral gastroenteritis.  On 09 Dec 2000 the patient developed a rash on his face which spread to his arms, a fever of 99.5 which was diagnosed as measles.  On 11 Dec 2000 the patient presented with a three day history of erythpetous patchy rash over trunk and extremities which appeared like rash of rubeola in derm books.  There were no koplick's spots, opharyngeal, erythema, lymphadenopathy, rhinorrhea of vesicles reported.  It was noted that the patient recovered.  It was also noted that the patient mother was checked for immunity and was immune.
she got sick; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 27May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "she got sick".  Additional information: Patient was scheduled to take the 2nd dose last 18Jun however she got sick then she called the facility and they told her that she still has 45 days after the 1st dose to get the 2nd dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Shingles on neck back of head.  Antiviral meds.  Issue resolved in six weeks
Within 24 hours of receiving the second dose of the COVID19 Moderna vaccine, I experienced a significant amount of tenderness at the injection site (right deltoid).   I also noticed significant hypersensitivity within my skin, throughout my entire body. The best way I can describe it is that I felt as though I had the  "pins and needles" sensation that one would experience after a limb has gone to sleep, but throughout my whole body from head to toe. I noticed this sensation when I woke around 6:30AM the day after I received the second dose, and it became progressively worse throughout the day. It lasted until about 7:00 PM, but only after I had taken some Tylenol about an hour or two before.
My lymph nodes in my neck and my throat swelled up. My throat became red and swollen. (The throat symptoms were within 2 hours and lymph nodes swelled up overnight) I became congested and started sneezing and coughing. I got a fever, chills, headache - within two hours, body aches, fatigue. The rest of the symptoms came within 24 hours. On Saturday morning, I called URGENT CARE - and they had me talk to  an Urgent Respiratory Care 50 mg of Benadryl and ibuprofen - 800 mg every 8hours   - Following Monday still very sick and I was seen on Monday at Urgent Respiratory Clinic and at that point of time they did a COVID test (January 11th). Told to take: Mucinex and nasal spray and antibiotic because my ears were so full at that time they were not draining. They helped reduce the symptoms. I was sick for the entire week. It took me out of work for a week.
Vaccine expiration date was 10/29/21, however date was listed on box in pharmacy refrigerator as 11/1/21. Expired vaccine was administered to the patient.
arm soreness at injection site (both vaccines); This is a spontaneous report from a contactable Other HCP (patient). A 61-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number EL0140), via an Intramuscular route of administration on left arm on 28Dec2020 12:00 at single dose for Covid-19 immunization administered at Hospital. The patient medical history included hypothyroidism and hyperlipidemia. Concomitant medication in two weeks of vaccination were not reported. No Allergies to medications, food, or other products was reported. The patient reported, arm soreness at injection site on an unspecified date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any treatment for the event. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has been tested for COVID-19. On 25Jan2021, the patient underwent lab test SARS-CoV-2 test Nasal Swab result-negative. The outcome of event was recovered.
Infant coughing and not eating well.  Vomited bile 3 times from 1 a.m. until 3 a.m.  In emergency room and put on fluids.  Started eating by mouth again at 8 a.m. on 09/03 and vomiting everything within minutes.  Vomited until 3 a.m. on 09/04.  Slowly starting to take food again and holding it down.  Fever was 100.4.  Diarrhea.
Information has been received concerning a pt who was vaccinated on 10/19/1999 with one dose of varicella vaccine. The pt's mother reported that on 06/26/00, the pt developed a varicella like rash. The nurse saw the pt and she had less than 50 lesions. it was also reported that information about exposure to wild type varicella was unknown at this time. Medical attention was sought.
numbness in the face; This is a spontaneous case received from a contactable Nurse. A 66-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 26Mar2021, as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, patient experienced "numbness in the face",  which was still ongoing. She had been experiencing it for over 2 weeks now after first dose of vaccine. Outcome of the event was not resolved.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.  Information about lot/batch number has been requested.
No adverse effects; patient was vaccinated with improperly stored MMR II; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.   On 15-MAR-2019, the patient was vaccinated with an improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) lot # R008031 and expiration date 18-MAR-2020 for prophylaxis (dosage schedule, route, and anatomical location were not reported). Other suspect therapy was sterile diluent for prophylaxis (dosage schedule, route, anatomical location, lot number and expiration date were not reported). The administered dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) experienced a temperature excursion above 9 degrees Celsius (8.59 C) for 15 minutes, and for sterile diluent experienced a temperature excursion above 1.18 degrees Celsius for 33 hours, as recorded by a data logger. There was no previous temperature excursion. No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1905USA001733:
Patient reports that he had typical myalgia following administration for "a few days." He then stated that about a week later he developed a constant "hurt or soreness" in that right arm that is worse when he has not moved his arm for a period of time. He states that he feels like he is losing muscle tone/experiencing atrophy in that right arm and that the pain extends from the deltoid muscle down toward the elbow.
Right shoulder pain Mar 27 10 AM through Mar 29, maximum pain Mar 27 evening to Mar 28 AM. Fatigue Mar 27 noon. Through Mar 29, maximum Mar 27 PM to Mar 28 AM. Chills Mar 27 5 PM through 11 PM. Nausea Mar 27 5 PM through 10 PM. Treatment - 2 ibuprofen Mar 27 10 PM.
On January 18 pt. developed mild itching over her entire body including head, she has no rash but reports red, blotchy skin. On January 22 the itching became "unbearable". She has not seen a doctor or taken medications for this condition.
Throat closing, hoarse, nauseous, almost passed out, sick for 2 days.
Saturday April 3,2021 shortness of breath went to hospital on April 12th with multiple unprovoked PE's Stayed in hospital 6 days and released without oxygen Given blood thinners to take for life Right side of heart damaged due to blood clots
Blurred vision . Lightheadedness. Soreness and tightness at site. Slight nausea.  Weakness and sluggishness, symptoms began to subside on 2nd evening. ( Identical with subsequent injection)
Patient received Pfizer Covid Omicron vaccine as a first dose in the primary series.  No adverse reaction.
The pt hlth appeared to thrive but between 3 and 4 months, the developmental delay started. It's been a gradual progression but with each round of vaccinations his development delays worsen. By 7 months his smiling, and laughing abated and he seemed to be retreating into his own world. To this date he is not sitting or crawling. The combined effects of the vaccinations have resulted in the pt's delayments. Pt also had the same vaccines on 9/18/00 and 11/15/00.
Lightheaded, dizziness, headache (4/10). Vitals wnl. Water and apple juice given.
Itching, cough. Given benadryl 50mg and epinephrine 0.3 in vaccine clinic, and taken to ED for further tx.